|
⚲
|
| Keyboard |
| Arbet-Engels Christophe
✚
|
|
|---|---|
| CIK # | 0001802615 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001802615] | |
| 4 | [0001802615] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Arbet-Engels Christophe | |
| Pharmathene Inc | |
| X4 Pharmaceuticals Inc | |
| Tempest Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pharmathene Inc ALT
Restricted Stock Units · derivative
|
2025-10-01 | Grant | 150,000 | $0.00 | |
|
Pharmathene Inc ALT
Stock Options (option to buy) · derivative
|
2025-10-01 | Grant | 450,000 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-02-12 | Grant | 850,000 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-01-24 | Sell | 11,624 | $0.45 | 5,231 |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-01-23 | Grant | 25,831 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Appreciation Right · derivative
|
2024-02-13 | Grant | 475,831 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2023-08-31 | Grant | 1,250,000 | $1.28 | 1,600,000 |
|
Tempest Therapeutics Inc MLND
Stock Option (right to buy) · derivative
|
2020-05-25 | Grant | 80,000 | $0.00 | |
|
Tempest Therapeutics Inc MLND
Employee Stock Option (right to buy) · derivative
|
2020-02-10 | Grant | 140,000 | $0.00 |